Peng Zhao

机构：Tianjin Medical University General Hospital, China Medical University · ORCID：0000-0003-2034-6810

发表论文 85 篇 · 总被引 1490 次 · h-index 20

代表论文

• NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study (2025 · Cancer Immunology Immunotherapy · 被引 14)
• SNPs Give LACTB Oncogene‐Like Functions and Prompt Tumor Progression via Dual‐Regulating p53 (2024 · Advanced Science · 被引 7)
• Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer (2025 · Journal of Nanobiotechnology · 被引 6)
• Cationizable transcytosis manganese nano-oxygenator for enhanced chemo-dynamic immunotherapy in deep tumour tissue (2024 · Journal of Materials Chemistry B · 被引 6)
• Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design (2025 · mAbs · 被引 4)
• Identification of shared neoantigens derived from frameshift mutations in the APC gene (2025 · Frontiers in Immunology · 被引 4)